$11.1 M

BSTG Mkt cap, 08-Oct-2018
Biostage Net income (Q1, 2019)-1.9 M
Biostage EBIT (Q1, 2019)-2 M
Biostage Cash, 31-Mar-20191.1 M

Biostage Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

22.0k93.0k118.0k82.0k

Revenue growth, %

323%27%(31%)

Cost of goods sold

11.0k48.0k139.0k116.0k

Gross profit

11.0k45.0k(21.0k)(34.0k)

Gross profit Margin, %

50%48%(18%)(41%)

Sales and marketing expense

259.0k329.0k289.0k

R&D expense

4.6m5.1m4.8m7.6m7.6m3.9m

General and administrative expense

4.0m5.7m6.6m4.5m3.9m3.9m

Operating expense total

8.8m11.1m11.7m12.1m11.5m7.8m

EBIT

(8.8m)(11.1m)(11.7m)(12.1m)(11.5m)(7.8m)

EBIT margin, %

(40077%)(11889%)(9916%)(14788%)

Pre tax profit

(11.1m)(11.7m)(11.6m)(11.9m)

Income tax expense

Net Income

(8.8m)(11.1m)(11.7m)(11.6m)(11.9m)(7.5m)

Biostage Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

14.0m5.3m7.5m2.9m4.0m1.3m

Accounts Receivable

21.0k42.0k

Inventories

38.0k75.0k

Current Assets

14.5m5.8m7.9m3.5m4.4m2.2m

PP&E

575.0k1.4m1.1m1.1m632.0k479.0k

Total Assets

15.1m7.2m9.0m4.6m5.0m2.6m

Accounts Payable

244.0k370.0k357.0k962.0k923.0k160.0k

Current Liabilities

495.0k710.0k654.0k2.8m1.6m662.0k

Total Liabilities

495.0k654.0k2.8m1.6m662.0k

Preferred Stock

Additional Paid-in Capital

16.5m19.4m32.9m37.9m50.2m57.7m

Retained Earnings

(2.0m)(13.0m)(24.7m)(36.3m)(48.2m)(55.8m)

Total Equity

14.6m6.5m8.3m1.8m3.4m2.0m

Financial Leverage

1 x1.1 x1.1 x2.6 x1.5 x1.3 x

Biostage Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(8.8m)(11.1m)(11.7m)(11.6m)(7.5m)

Depreciation and Amortization

158.0k363.0k478.0k454.0k413.0k261.0k

Accounts Receivable

(16.0k)(21.0k)42.0k

Inventories

(38.0k)(169.0k)75.0k

Accounts Payable

65.0k126.0k(13.0k)472.0k(43.0k)(763.0k)

Cash From Operating Activities

(7.7m)(8.0m)(7.2m)(9.1m)(11.0m)(7.6m)

Purchases of PP&E

(295.0k)(1.2m)(176.0k)(302.0k)(136.0k)(131.0k)

Cash From Investing Activities

(295.0k)(1.2m)(176.0k)(302.0k)(136.0k)(67.0k)

Cash From Financing Activities

22.0m420.0k9.6m4.8m12.2m5.0m

Biostage Ratios

USDY, 2019

Financial Leverage

1.7 x

Biostage Employee Rating

00 votes
Culture & Values
N/A
Work/Life Balance
N/A
Senior Management
N/A
Salary & Benefits
N/A
Career Opportunities
N/A
Source